STOCK TITAN

FIG (NYSE: FIG) trusts report multiple 10b5-1 sales, files resale notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

FIG - Proposed sale of 10,000 common shares by trusts/related holders. The filing lists 10,000 shares identified for sale through Morgan Stanley Smith Barney LLC (New York), originating from estate planning transfers acquired 12/13/2018. The excerpt also reports multiple 10b5-1 programmed sales completed earlier in 2026, including transactions of 150,000, 29,331, 30,000, and other share lots with corresponding proceeds shown.

The filing names beneficiaries and trusts (for example, Olivia Mae Rasmussen Irrevocable Trust U/A DTD 05/16/2025) as sellers and records sale dates and gross proceeds for each prior transaction. The notice lists the broker-dealer and trading venue as Morgan Stanley Smith Barney LLC and NYSE.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice of planned resale and recent Rule 10b5-1 dispositions.

The filing lists a proposed resale of 10,000 common shares via Morgan Stanley Smith Barney LLC and documents multiple completed 10b5-1 sales earlier in 2026 with explicit share counts and gross proceeds. The presence of dated trading-plan sales is the operative disclosure for market timing and transfer mechanics.

Cash‑flow treatment: the excerpt attributes gross proceeds to each sale row; the filing does not state net proceeds remitted to the issuer. Subsequent SEC disclosures or transaction confirmations would show final settlement details.

Large programmed dispositions visible; concentration in several March 2026 trades.

The excerpt records a significant programmed sale of 150,000 shares on 03/03/2026 plus other multi‑lot dispositions. These transactions are identified as 10b5-1 sales and list per‑trade gross proceeds in dollars, indicating routine, pre‑arranged liquidity actions rather than discretionary open‑market timing disclosed here.

Timing and additional impact: the excerpt provides concrete dates for prior sales; no forward schedule or limits for the 10,000-share notice are provided in this excerpt.

Proposed resale 10,000 shares listed for resale; acquired 12/13/2018
Large 10b5-1 sale 150,000 shares sale dated 03/03/2026 with proceeds $4,470,720.00
Notable lot 29,331 shares sale dated 03/03/2026 with proceeds $874,204.54
Notable lot 30,000 shares sale dated 02/25/2026 with proceeds $900,249.00
Minor trust sales 5,000 shares multiple 10b5-1 sales on 02/17/2026 and 03/16/2026 with proceeds ~ $115,000–$134,455
10b5-1 regulatory
"10b5-1 Sales for OLIVIA MAE RASMUSSEN IRREV TRUST"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Irrevocable Trust legal
"OLIVIA MAE RASMUSSEN IRREV TRUST U/A DTD 05/16/2025"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Estate Planning Transfers legal
"Estate Planning Transfers | Acquired from the Settlor of the Trust"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does FIG's Form 144 disclose about the 10,000 shares?

The Form 144 lists a proposed resale of 10,000 common shares held by trusts and routed through Morgan Stanley Smith Barney LLC; the shares were acquired 12/13/2018 and are tied to estate planning transfers.

Which parties executed recent sales reported in the filing for FIG?

The filing shows multiple 10b5-1 programmed sales by named trusts and an individual (e.g., Kriskopher Rasmussen), including a 150,000-share sale on 03/03/2026 and various other dated lots in February–March 2026.

Were the recent transactions in the filing pre‑arranged under trading plans?

Yes. The excerpt labels the recorded dispositions as 10b5-1 Sales, indicating they were effected under pre-arranged trading plans for the named trusts and individuals in the excerpt.

What broker and exchange are listed for the proposed sale?

The proposed resale is routed through Morgan Stanley Smith Barney LLC (New York), and the trading venue listed in the excerpt is the NYSE.

Do the reported sale rows state proceeds for each transaction?

Yes. Each reported prior sale row in the excerpt includes a gross dollar amount alongside share counts (for example, 150,000 shares for $4,470,720.00 on 03/03/2026), showing per‑trade gross proceeds.